专利检索 ap:("Global Blood Therapeutics, Inc.") AND inv:"BEJUGAM, Naveen" 第 1 页

1.

发明公开
TABLETS COMPRISING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 审中-公开

公开(公告)号：EP3525766A1

公开(公告)日：2019-08-21

申请号：EP17790926.4

申请日：2017-10-12

申请人： Global Blood Therapeutics, Inc.

发明人： DALZIEL, Sean Mark , BEJUGAM, Naveen , HABIBIZAD, Nazila , KOMEYLI, Ali , LEUNG, DeMei

IPC分类号： A61K9/20 , A61K31/4439 , A61P7/06 , A61P11/00

2.

发明公开
TABLETS COMPRISING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 审中-公开

公开(公告)号：EP4461357A2

公开(公告)日：2024-11-13

申请号：EP24197031.8

申请日：2017-10-12

申请人： Global Blood Therapeutics, Inc.

发明人： DALZIEL, Sean Mark , BEJUGAM, Naveen , HABIBIZAD, Nazila , KOMEYLI, Ali , LEUNG, DeMei

IPC分类号： A61P11/00

摘要： Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ("Compound 1"), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.

3.

发明公开
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 审中-公开

公开(公告)号：EP3383392A1

公开(公告)日：2018-10-10

申请号：EP16813299.1

申请日：2016-12-02

申请人： Global Blood Therapeutics, Inc.

发明人： RAMOS, Eleanor, L. , LEHRER-GRAIWER, Joshua, Eli , HUTCHALEELAHA, Athiwat , BEJUGAM, Naveen

IPC分类号： A61K31/4439 , A61K9/48 , A61P35/02

CPC分类号： A61K31/4439 , A61K9/1605 , A61K9/4858 , A61K9/4866

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.